Immunosuppressant Drug Monitoring Market: By Product (Equipment, Consumables) By Technology (Proteomics Technologies, Immunoassays, Electrophoresis, Spectrometry) By Drugs (Antibodies, Corticosteroids, Calcineurin Inhibitors, Anti-Proliferative Agents, mTOR Inhibitors, Others) By Disease (Autoimmune Disorders, Organ Transplantation, Non-Auto Immune Inflammatory Diseases) By End User (Hospitals, Diagnostic Laboratories, Research Institutes, Academic Institutes) By Geography (Latin America, North America, Asia Pacific, The Middle East and Africa and Europe)


Purchase Option

$ 3000
$ 4400
$ 6600
$ 8900

Immunosuppressant drug monitoring is most vital for monitoring of immunosuppressant drug levels in patients in order to prevent the organ rejection. It is one of the applications of therapeutic drug monitoring, aims to maintain the adequate concentration of drugs in body fluids in order to refine patient care by adjusting individual drug dosage for the better outcomes. Immunosuppressant drugs are known as anti-rejection drugs, which inhibits the activity of immune system that are most commonly used in organ transplantations, auto immune disorders like multiple sclerosis, rheumatoid arthritis and chron’s disease.  Growing demand for organ transplantations, advancements in procedures of organ transplantation, growing prevalence of auto immune diseases are expected to witness tremendous growth of the immunosuppressant drug monitoring market. Furthermore, favorable reimbursement policies, growing awareness among the people regarding healthcare and organ transplantations are expected to fuel immunosuppressant drug monitoring market. However, strict regulatory frameworks, availability of alternative therapies like stem cell therapy for immunosuppression are expected to hamper the growth of immunosuppressant drug monitoring market. Therapeutic drug monitoring is a method of determining the drug's safe and effective dosage. Therapeutic Drug Monitoring is a technique for treating and monitoring drug concentrations in body fluids, most often plasma. A major element driving the global market's growth is the growing demand for better healthcare facilities in developing countries to meet the needs of a growing urban population. Furthermore, the growing elderly population and the development of novel medication management systems, particularly in emerging nations, are two major drivers driving market expansion.

Immunosuppressant Drug Monitoring Market Summary

Study Period


Base Year




Largest Market

North America

Fastest Growing Market

Immunosuppressant Drug Monitoring Market Dynamics

Immunosuppressant drug monitoring market is growing at a significant rate due to rise in prevalence of autoimmune disorders and organ transplantations. As per WHO statistics, about 119,873 organ transplantation cases were reported in 2014, raised about 1.8% from 2013. Growing prevalence of autoimmune disorders and rise in investments in R&D activities for innovation of new procedures are expected to propel the immunosuppressant drug monitoring market over the forecast timeframe. Moreover, acquisitions and mergers, new product approvals, and product launches are major strategies followed by market players for increasing the revenue in immunosuppressant drug monitoring market.

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2018 to 2022) and forecast (2023 to 2029)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

Immunosuppressant Drug Monitoring Market Segmentation

By Product Type
  • Equipment
  • Consumables
By Technology
  • Proteomics Technologies
  • Immunoassays
  • Electrophoresis
  • Spectrometry
By Drugs
  • Antibodies
  • Corticosteroids
  • Calcineurin inhibitors
  • Anti-proliferative agents
  • mTOR inhibitors
  • Others
By End User
  • Hospitals
  • Diagnostic laboratories
  • Research Institutes
  • Academic Institutes

Frequently Asked Questions

2021 is the base year and 2028 is the forecast year.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.

[urltag url='request-table-of-content']
  • Thermo Fisher Scientific
  • Hoffmann-La Roche AG
  • Bio-Rad Laboratories Inc.
  • Abbott Laboratories
  • Siemens Healthcare
  • Danaher Corporation